tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market

Werewolf Therapeutics (HOWL) Financial Statements

Compare
644 Followers

Werewolf Therapeutics Financial Overview

Werewolf Therapeutics's market cap is currently $35.53M. The company's EPS TTM is $-1.625; its P/E ratio is ―; Werewolf Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.89M$ 19.94M$ 16.40M$ 0.00$ 0.00
Gross Profit$ 1.89M$ -18.96M$ 13.89M$ -735.00K$ -777.00K
Operating Income$ -73.59M$ -40.50M$ -56.06M$ -50.09M$ -22.40M
EBITDA$ -64.05M$ -32.47M$ -51.30M$ -49.25M$ -14.26M
Net Income$ -70.52M$ -37.37M$ -51.56M$ -49.77M$ -14.94M
Balance Sheet
Cash & Short-Term Investments$ 112.22M$ 134.34M$ 129.31M$ 157.53M$ 92.57M
Total Assets$ 126.93M$ 174.83M$ 160.25M$ 179.25M$ 96.40M
Total Debt$ 10.99M$ 51.92M$ 14.68M$ 15.66M$ 2.54M
Net Debt$ -101.22M$ -82.42M$ -114.63M$ -141.87M$ -90.03M
Total Liabilities$ 53.54M$ 63.46M$ 37.91M$ 26.46M$ 148.26M
Stockholders' Equity$ 73.39M$ 111.37M$ 122.34M$ 152.79M$ -51.86M
Cash Flow
Free Cash Flow$ -56.44M$ -33.38M$ -44.21M$ -43.37M$ -19.18M
Operating Cash Flow$ -56.19M$ -32.61M$ -40.60M$ -42.88M$ -18.62M
Investing Cash Flow$ -254.00K$ -769.00K$ -3.61M$ -498.00K$ -560.00K
Financing Cash Flow$ 13.08M$ 58.43M$ 15.91M$ 109.43M$ 93.86M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Werewolf Therapeutics Debt to Assets

Werewolf Therapeutics Cash Flow

Werewolf Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis